ARTICLE | Clinical News

Nymox preclinical data

December 3, 2001 8:00 AM UTC

NYMX said that in a rat model of BPH, treatment with NX 1207 gave up to 50% reductions in prostate size compared to placebo. In addition, in vitro treatment of human prostate cancer tissue with NX 120...